CHC Healthcare Group announced yesterday that construction has begun on a medical park located on its own land in Yangmei. The park will include a residential long-term care facility and a local hospital, with completion expected in 2027, marking the company’s entry into the long-term care business. At the same time, the group’s Fukang Pharmacy network has grown to 60 locations and plans to continue expanding. The goal is to reach 80 locations by the end of this year and surpass 100 by next year. Additionally, the company is preparing for an initial public offering (IPO) for Fukang Pharmacy, with plans to enter the capital market by 2027.
Following the Lunar New Year, CHC Healthcare’s stock price has surged, reaching NT$51.7 today, a more than 6% increase. Since the Lunar New Year, the stock has risen by over 16%, marking the highest price in six months. The company stated that its medical equipment distribution business has seen strong orders, even during the traditionally slower first quarter, with a year-on-year growth rate of up to 30%. As deliveries continue, the company expects its operations to grow quarter by quarter, with annual revenue likely to see double-digit growth, reaching new historical highs for both revenue and profit.
In addition to strong demand for medical equipment, CHC Healthcare is optimistic about its radiation facility in Miaoli, which began operations in the second half of last year. This year, the demand for medical devices is expected to increase significantly. Moreover, several semiconductor and aerospace-related clients are expected to begin testing and validation in the first half of the year, with a potential volume increase in the second half, which will be beneficial for the radiation facility to start generating profits.
CHC Healthcare also made progress in its pharmacy business. Last year, Fukang Pharmacy acquired the local chain "Happy Pharmacy" in Hsinchu, adding 10 new locations. While Fukang pharmacies were previously concentrated in the northern and Taipei areas, this acquisition marks the first expansion into Hsinchu. The company plans to continue seeking suitable locations in the central and southern regions this year to further expand its network.
CHC Healthcare reported that Fukang Pharmacy’s revenue exceeded NT$1 billion last year and expects double-digit growth this year, driven by the continued expansion of its stores. As the pharmacy chain solidifies its position in the market, the company aims to gain a foothold in the capital market and has already begun preparing for internal audits and controls, working toward the IPO goal.
Regarding its expansion into the long-term care business, the company is focusing on Taiwan’s current shortage of residential long-term care facilities. The land in Yangmei was acquired several years ago and will be developed into a medical park. The long-term care facility will provide 300 beds to address the domestic gap in long-term care services. Additionally, a local medical institution will be established within the park, offering 100 beds for chronic disease care.
Resource: 承業醫跨長照事業醫療園區上半年動工 將推動富康藥局掛牌
